Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 1, 2008, Pages 183-191

  Buchholz, Kathrin ^a,b   Schirmer, R Heiner ^a   Eubel, Jana K ^a   Akoachere, Monique B ^b   Dandekar, Thomas ^c   Becker, Katja ^b   Gromer, Stephan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDE; CYSTEINE; DIHYDROLIPOAMIDE DEHYDROGENASE; DISULFIDE REDUCTASE; DITHIOL DERIVATIVE; GLUTATHIONE; HYDROGEN PEROXIDE; LEUCOMETHYLENE BLUE; LIPID; METHYLENE BLUE; OXIDOREDUCTASE; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN; UNCLASSIFIED DRUG;

ACIDITY; AEROBIC METABOLISM; ALKALINITY; ARTICLE; AUTOOXIDATION; CATALYSIS; CATALYST; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; HUMAN; KINETICS; NONHUMAN; ORTHOLOGY; OXIDATION REDUCTION REACTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REACTION ANALYSIS; REDUCTION;

AEROBIOSIS; ANIMALS; BINDING SITES; DISULFIDES; HUMANS; HYDROGEN-ION CONCENTRATION; KINETICS; METHYLENE BLUE; OXIDATION-REDUCTION; OXIDOREDUCTASES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SUBSTRATE SPECIFICITY;

EID: 37849030399     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00773-07     Document Type: Article

References (59)

1. Adamcikova, L., and P. Sevcik. 1998. The blue bottle experiment - simple demonstration of self-organisation. J. Chem. Educ. 75:1580.
2. Akoachere, M., K. Buchholz, E. Fischer, J. Burhenne, W. E. Haefeli, R. H. Schirmer, and K. Becker. 2005. In vitro assessment of methylene blue on chloroquine-sensitive and -resistant Plasmodium falciparum strains reveals synergistic action with artemisinins. Antimicrob. Agents Chemother. 49: 4592-4597.
3. Antonov, L., G. Gergov, V. Petrov, M. Kubista, and J. Nygren. 1999. UV-Vis spectroscopic and chemometric study on the aggregation of ionic dyes in water. Talanta 49:99-106.
4. Argyrou, A., and J. S. Blanchard. 2004. Flavoprotein disulfide reductases: advances in chemistry and function. Prog. Nucleic Acid Res. Mol. Biol. 78:89-142.
5. 4 level. Biochemistry 42:2218-2228.
6. Atamna, H., M. Krugliak, G. Shalmiev, E. Deharo, G. Pescarmona, and H. Ginsburg. 1996. Mode of antimalarial effect of methylene blue and some of its analogues on Plasmodium falciparum in culture and their inhibition of P. vinckei petteri and P. yoelii nigeriensis in vivo. Biochem. Pharmacol. 51:693-700.
7. Bauer, H., K. Fritz-Wolf, A. Winzer, S. Kühner, S. Little, V. Yardley, H. Vezin, B. Palfey, R. H. Schirmer, and E. Davioud-Charvet. 2006. A fluoro analogue of the menadione derivative 6-[2′-(3′-methyl)- 1′,4′-naphthoquinolyl]hexanoic acid is a suicide substrate of glutathione reductase. Crystal structure of the alkylated human enzyme. J. Am. Chem. Soc. 128:10784-10794.
8. Bauer, H., S. M. Kanzok, and R. H. Schirmer. 2002. Thioredoxin-2 but not thioredoxin-1 is a substrate of thioredoxin peroxidase-1 from Drosophila melanogaster: isolation and characterization of a second thioredoxin in D. melanogaster and evidence for distinct biological functions of Trx-1 and Trx-2. J. Biol. Chem. 277:17457-17463.
9. Becker, K., S. Koncarevic, and N. H. Hunt. 2005. Oxidative stress and antioxidant defense in malarial parasites, p. 365-383. In I. Sherman (ed.), Molecular approaches to malaria. ASM Press, Washington, DC.
10. Becker, K., S. Rahlfs, C. Nickel, and R. H. Schirmer. 2003. Glutathione - functions and metabolism in the malarial parasite Plasmodium falciparum. Biol. Chem. 384:551-566.
11. Becker, K., and R. H. Schirmer. 2007. Antioxidative Enzyme des Malariaer-regers als Drug-Targets. BIOspektrum 13:138-141.
12. Biot, C., H. Bauer, R. H. Schirmer, and E. Davioud-Charvet. 2004. 5-substituted tetrazoles as bioisosteres of carboxylic acids. Bioisosterism and mechanistic studies on glutathione reductase inhibitors as antimalarials. J. Med. Chem. 47:5972-5983.
13. Blumenstiel, K., R. Schöneck, V. Yardley, S. L. Croft, and R. L. Krauth-Siegel. 1999. Nitrofuran drugs as common subversive substrates of Trypanosoma cruzi lipoamide dehydrogenase and trypanothione reductase. Biochem. Pharmacol. 58:1791-1799.
14. Boda, C., B. Enanga, B. Courtioux, J. C. Breton, and B. Bouteille. 2006. Trypanocidal activity of methylene blue. Evidence for in vitro efficacy and in vivo failure. Chemotherapy 52:16-19.
15. Böhme, C. C., L. D. Arscott, K. Becker, R. H. Schirmer, and C. H. Williams, Jr. 2000. Kinetic characterization of glutathione reductase from the malarial parasite Plasmodium falciparum. Comparison with the human enzyme. J. Biol. Chem. 275:37317-37323.
16. Bradberry, S. M. 2003. Occupational methaemoglobinaemia. Mechanisms of production, features, diagnosis and management including the use of methylene blue. Toxicol. Rev. 22:13-27.
17. Cawein, M., C. H. Behlen II, E. J. Lappat, and J. E. Cohn. 1964. Hereditary diaphorase deficiency and methemoglobinemia. Arch. Intern. Med. 113:578-585.
18. Cenas, N. K., L. D. Arscott, C. H. Williams, Jr., and J. S. Blanchard. 1994. Mechanism of reduction of quinones by Trypanosoma congolense trypanothione reductase. Biochemistry 33:2509-2515.
19. Cenas, N. K., G. A. Rakauskiene, and J. J. Kulys. 1989. One- and two-electron reduction of quinones by glutathione reductase. Biochim. Biophys. Acta 973:399-404.
20. Clark, W. M., B. Cohen, and H. D. Gibbs. 1925. Studies on oxidation-reduction VIII - methylene blue. U.S. Public Health Rep. 40:1131-1201.
21. Dilgin, Y., and G. Nisli. 2005. Fluorimetric determination of ascorbic acid in vitamin C tablets using methylene blue. Chem. Pharm. Bull. (Tokyo) 53: 1251-1254.
22. Ellman, G. L. 1959. Tissue sulfhydryl groups. Arch. Biochem. Biophys. 82: 70-77.
23. Färber, P. M., L. D. Arscott, C. H. Williams, Jr., K. Becker, and R. H. Schirmer. 1998. Recombinant Plasmodium falciparum glutathione reductase is inhibited by the antimalarial dye methylene blue. FEBS Lett. 422:311-314.
24. Gromer, S., L. D. Arscott, C. H. Williams, Jr., R. H. Schirmer, and K. Becker. 1998. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J. Biol. Chem. 273:20096-20101.
25. Gromer, S., H. Merkle, R. H. Schirmer, and K. Becker. 2002. Human placenta thioredoxin reductase: preparation and inhibitor studies. Methods Enzymol. 347:382-394.
26. Gromer, S., S. Urig, and K. Becker. 2004. The thioredoxin system - from science to clinic. Med. Res. Rev. 24:40-89.
27. Gromer, S., L. A. Wessjohann, J. Eubel, and W. Brandt. 2006. Mutational studies confirm the catalytic triad in the human selenoenzyme thioredoxin reductase predicted by molecular modeling. Chembiochem 7:1649-1652.
28. Guttmann, P., and P. Ehrlich. 1891. Über die Wirkung des Methylenblau bei Malaria. Berl. Klin. Wochenschr. 28:953-956.
29. Kanzok, S. M., R. H. Schirmer, I. Türbachova, R. Iozef, and K. Becker. 2000. The thioredoxin system of the malaria parasite Plasmodium falciparum. Glutathione reduction revisited. J. Biol. Chem. 275:40180-40186.
30. Karplus, P. A., E. F. Pai, and G. E. Schulz. 1989. A crystallographic study of the glutathione binding site of glutathione reductase at 0.3-nm resolution. Eur. J. Biochem. 178:693-703.
31. Kelner, M. J., and N. M. Alexander. 1985. Methylene blue directly oxidizes glutathione without the intermediate formation of hydrogen peroxide. J. Biol. Chem. 260:15168-15171.
32. Kosower, E. M. 1987. Structure and reaction of thiols with special emphasis on glutathione, p. 103-146. In D. Dolphin, R. Poulson, and O. Avramovic (ed.), Coenzymes and cofactors, vol. IIIA. John Wiley & Sons, New York, NY.
33. Krauth-Siegel, R. L., L. D. Arscott, A. Schönleben-Janas, R. H. Schirmer, and C. H. Williams, Jr. 1998. Role of active site tyrosine residues in catalysis by human glutathione reductase. Biochemistry 37:13968-13977.
34. Krauth-Siegel, R. L., H. Bauer, and R. H. Schirmer. 2005. Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew Chem. 44: 690-715.
35. Low, F. M., M. B. Hampton, A. V. Peskin, and C. C. Winterbourn. 2007. Peroxiredoxin-2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109:2611-2617.
36. Mansouri, A., and A. A Lurie. 1993. Concise review: methemoglobinemia. Am. J. Hematol. 42:7-12.
37. Massey, V. 1960. The identity of diaphorase and lipoyl dehydrogenase. Biochim. Biophys. Acta 37:314-322.
38. McMillan, P. J., L. M. Stimmler, B. J. Foth, G. I. McFadden, and S. Müller. 2005. The human malaria parasite Plasmodium falciparum possesses two distinct dihydrolipoamide dehydrogenases. Mol. Microbiol. 55:27-38.
39. Meissner, P. E., G. Mandi, B. Coulibaly, S. Witte, T. Tapsoba, U. Mansmann, J. Rengelshausen, W. Schiek, A. Jahn, I. Walter-Sack, G. Mikus, J. Burhenne, K.-D. Riedel, R. H. Schirmer, B. Kouyaté, and O. Müller. 2006. Methylene blue for malaria in Africa: results from a dose-finding study in combination with chloroquine. Malar. J. 5:84.
40. Meissner, P. E., G. Mandi, S. Witte, B. Coulibaly, U. Mansmann, J. Rengelshausen, W. Schiek, A. Jahn, M. Sanon, T. Tapsoba, I. Walter-Sack, G. Mikus, J. Burhenne, K.-D. Riedel, H. Schirmer, B. Kouyaté, and O. Müller. 2005. Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso. Malar. J. 4:45.
41. 2: an ambiguous system? J. Photochem. Photobiol. A Chem. 127:123-134.
42. Müller, S., T. W. Gilberger, P. M. Färber, K. Becker, R. H. Schirmer, and R. D. Walter. 1996. Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol. Biochem. Parasitol. 80:215-219.
43. Müller, S., T. W. Gilberger, Z. Krnajski, K. Luersen, S. Meierjohann, and R. D. Walter. 2001. Thioredoxin and glutathione system of the malaria parasite Plasmodium falciparum. Protoplasma 217:43-49.
44. Nordhoff, A., U. S. Bücheier, D. Werner, and R. H. Schirmer. 1993. Folding of the four domains and dimerization are impaired by the Gly446→Glu exchange in human glutathione reductase. Implications for the design of antiparasitic drugs. Biochemistry 32:4060-4066.
45. 4NBr and urea. Phys. Chem. Chem. Phys. 2:4313-4317.
46. Prahl, S. 4 March 1999, posting date. Optical absorption of methylene blue. Oregon Medical Laser Center, Beaverton, OR. http://omlc.ogi.edu/ spectra /mb/index.html.
47. Rengelshausen, J., J. Burhenne, M. Fröhlich, Y. Tayrouz, S. K. Singh, K.-D. Riedel, O. Müller, T. Hoppe-Tichy, W. E. Haefeli, G. Mikus, and I. Walter-Sack. 2004. Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria. Eur. J. Clin. Pharmacol. 60:709-715.
48. Rosin, D. 1893. Quinine and methylene blue in malaria. Dtsche. Med. Wochenschr. 44:Editorial.
49. Sarma, G. N., S. N. Savvides, K. Becker, M. Schirmer, R. H. Schirmer, and P. A. Karplus. 2003. Glutathione reductase of the malarial parasite Plasmodium falciparum: crystal structure and inhibitor development. J. Mol. Biol. 328:893-907.
50. Schafer, F. Q., and G. R. Buettner. 2001. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 30:1191-1212.
51. Schirmer, R. H., B. Coulibaly, A. Stich, M. Scheiwein, H. Merkle, J. Eubel, K. Becker, H. Becher, O. Müller, T. Zich, W. Schiek, and B. Kouyaté. 2003. Methylene blue as an antimalarial agent. Redox Rep. 8:272-275.
52. Thurston, J. P. 1953. The chemotherapy of Plasmodium berghei. I. Resistance to drugs. Parasitology 43:246-252.
53. Vennerstrom, J. L., M. T. Makler, C. K. Angerhofer, and J. A. Williams. 1995. Antimalarial dyes revisited: xanthenes, azines, oxazines, and thiazines. Antimicrob. Agents Chemother. 39:2671-2677.
54. Wainwright, M., and L. Amaral. 2005. The phenothiazinium chromophore and the evolution of antimalarial drugs. Trop. Med. Int. Health 10:501-511.
55. Weber, F. P. 1901. The occurrence of green or blue urine and its most frequent cause. Lancet 2:774.
56. Williams, C. H., Jr. 1992. Lipoamide dehydrogenase, glutathione reductase, thioredoxin reductase, and mercuric ion reductase - a family of flavoenzyme transhydrogenases, p. 121-211. In F. Müller (ed.), Chemistry and biochemistry of flavoenzymes, vol. 3. CRC Press, Boca Raton, FL.
57. Wolff, S. P., and M. J. Crabbe. 1985. Low apparent aldose reductase activity produced by monosaccharide autoxidation. Biochem. J. 226:625-630.
58. Yi, P. G., J. F. Liu, Z. C. Shang, and Q. S. Yu. 2001. Study on the interaction between methylene blue and bovine serum albumin by fluorescence spectroscopy. Guang Pu Xue Yu Guang Pu Fen Xi 21:826-828. (In Chinese.)
59. Zappe, H. A. 1980. Die Bindungsstellen Hämolyse-induzierender Pharmaka an der Glutathionreduktase aus menschlichen Erythrocyten. Röntgenstrukturanalyse von Enzym-Pharmakon-Komplexen. Heidelberg University, Heidelberg, Germany.